16-Jan-2026
Trump says he is “getting rid” of healthcare middlemen
Seeking Alpha News (Fri, 16-Jan 11:36 AM ET)
Obamacare enrollment shows faulty CBO forecast - WSJ Editorial Board
Seeking Alpha News (Fri, 16-Jan 6:09 AM ET)
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Penumbra (PEN)
TipRanks (Thu, 15-Jan 4:30 PM ET)
Trump unveils 'Great Healthcare Plan' to lower drug prices, premiums
Seeking Alpha News (Thu, 15-Jan 11:38 AM ET)
Trump admin rolls back $2B in mental health, addiction grant cuts—report
Seeking Alpha News (Thu, 15-Jan 6:49 AM ET)
Obamacare enrollments drop nearly 1M amid premium hikes
Seeking Alpha News (Wed, 14-Jan 8:50 AM ET)
UnitedHealth stock slips on report of Medicare ‘aggressive tactics’
Seeking Alpha News (Mon, 12-Jan 7:11 AM ET)
Elevance Health Reflects On The Changed Role of Health Plans
Business Wire (Fri, 12-Dec 2:00 PM ET)
AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries
Business Wire (Fri, 12-Dec 11:10 AM ET)
Business Wire (Wed, 10-Dec 4:30 PM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of January 16, 2026, ELV stock price declined to $374.87 with 937,453 million shares trading.
ELV has a beta of 0.27, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.02 to the broad based SPY ETF.
ELV has a market cap of $83.31 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $50 billion in Revenue and $6.03 earnings per share. This beat revenue expectation by $579 million and exceeded earnings estimates by $1.07.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has underperformed the market in the last year with a return of -0.9%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ELV shares. However, ELV has outperformed the market in the last 3 month and 2 week periods, returning +8.2% and +5.8%, while SPY returned +5.0% and +1.2%, respectively. This indicates ELV has been having a stronger performance recently.
ELV support price is $376.09 and resistance is $387.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.